Literature DB >> 24264534

Contemporary neurosurgical techniques for pituitary tumor resection.

John Y K Lee1, Leif-Erik Bohman, Marvin Bergsneider.   

Abstract

Approximately 5,000 trans-sphenoidal surgeries are performed for resection of pituitary tumors each year in the United States. The rise in popularity of the trans-spehnoidal approach, though described nearly a century ago, has been facilitated over the last decades by advances in technique and technology. In this review, we discuss the relative strengths of microscopic and endoscopic techniques for pituitary tumor resection. However, despite being the standard of care for patients with most pituitary tumors, cure rates for many subtypes of pituitary lesions, such as secretory macroadenomas or tumors with significant cavernous sinus invasion, remain unsatisfactory. We also describe two more recent advances in neurosurgical technique which may offer promise of increased rates of surgical cure: pseudocapsular resection and cavernous sinus approaches.

Entities:  

Mesh:

Year:  2013        PMID: 24264534     DOI: 10.1007/s11060-013-1315-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  77 in total

1.  Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.

Authors:  P De; D A Rees; N Davies; R John; J Neal; R G Mills; J Vafidis; J S Davies; M F Scanlon
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

2.  Barrier-limited multimodality closure for reconstruction of wide sellar openings.

Authors:  Marvin Bergsneider; Kai Xue; Jeffrey D Suh; Marilene B Wang
Journal:  Neurosurgery       Date:  2012-09       Impact factor: 4.654

Review 3.  Editorial: Unresolved issues: radiosurgery versus radiation therapy; medical suppression of growth hormone production during radiosurgery; and endoscopic surgery versus microscopic surgery.

Authors:  Edward H Oldfield
Journal:  Neurosurg Focus       Date:  2010-10       Impact factor: 4.047

4.  Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease.

Authors:  Jay Jagannathan; Rene Smith; Hetty L DeVroom; Alexander O Vortmeyer; Constantine A Stratakis; Lynnette K Nieman; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

Review 5.  The pseudocapsule surrounding a pituitary adenoma and its clinical significance.

Authors:  Xin Qu; Guangming Xu; Yuanming Qu; Tao Song
Journal:  J Neurooncol       Date:  2010-06-06       Impact factor: 4.130

6.  A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap.

Authors:  Gustavo Hadad; Luis Bassagasteguy; Ricardo L Carrau; Juan C Mataza; Amin Kassam; Carl H Snyderman; Arlan Mintz
Journal:  Laryngoscope       Date:  2006-10       Impact factor: 3.325

Review 7.  Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.

Authors:  N Sanno; A Teramoto; R Y Osamura
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 8.  Pituitary centers of excellence.

Authors:  Nancy McLaughlin; Edward R Laws; Nelson M Oyesiku; Laurence Katznelson; Daniel F Kelly
Journal:  Neurosurgery       Date:  2012-11       Impact factor: 4.654

9.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

10.  Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma?

Authors:  Eun Jig Lee; Jung Yong Ahn; Taewoong Noh; Se Hun Kim; Tai Seung Kim; Sun Ho Kim
Journal:  Neurosurgery       Date:  2009-03       Impact factor: 4.654

View more
  7 in total

1.  Endoscopic endonasal transsellar approach for laterally extended pituitary adenomas: volumetric analysis of cavernous sinus invasion.

Authors:  Masaaki Taniguchi; Kohkichi Hosoda; Nobuyuki Akutsu; Yutaka Takahashi; Eiji Kohmura
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

2.  Clinical characteristics of acromegalic patients with empty sella and their outcomes following transsphenoidal surgery.

Authors:  Yasuo Sasagawa; Yasuhiko Hayashi; Osamu Tachibana; Masahiro Oishi; Issei Fukui; Hideaki Iizuka; Mitsutoshi Nakada
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

3.  Folate Receptor Near-Infrared Optical Imaging Provides Sensitive and Specific Intraoperative Visualization of Nonfunctional Pituitary Adenomas.

Authors:  Steve S Cho; Ryan Zeh; John T Pierce; Jun Jeon; MacLean Nasrallah; Nithin D Adappa; James N Palmer; Jason G Newman; Caitlin White; Julia Kharlip; Peter Snyder; Philip Low; Sunil Singhal; M Sean Grady; John Y K Lee
Journal:  Oper Neurosurg (Hagerstown)       Date:  2019-01-01       Impact factor: 2.703

4.  Comparative Cost Analysis of Endoscopic versus Microscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas.

Authors:  Chikezie Ikechukwu Eseonu; Karim ReFaey; Oscar Garcia; Roberto Salvatori; Alfredo Quinones-Hinojosa
Journal:  J Neurol Surg B Skull Base       Date:  2017-08-08

5.  Indocyanine-Green for Fluorescence-Guided Surgery of Brain Tumors: Evidence, Techniques, and Practical Experience.

Authors:  Steve S Cho; Ryan Salinas; John Y K Lee
Journal:  Front Surg       Date:  2019-03-12

6.  A small 3D-printing model of macroadenomas for endoscopic endonasal surgery.

Authors:  Xing Huang; Zhen Liu; Xuan Wang; Xu-Dong Li; Kai Cheng; Yan Zhou; Xiao-Bing Jiang
Journal:  Pituitary       Date:  2019-02       Impact factor: 4.107

7.  Improvement in the Quality of Early Postoperative Course After Endoscopic Transsphenoidal Pituitary Surgery: Description of Surgical Technique and Outcome.

Authors:  Xinfa Pan; Yuehui Ma; Minwei Fang; Jiajing Jiang; Jie Shen; Renya Zhan
Journal:  Front Neurol       Date:  2020-10-20       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.